1 / 27

Topics in High Risk OB Advanced maternal age, Twins, VBAC, Preterm labor

Topics in High Risk OB Advanced maternal age, Twins, VBAC, Preterm labor. Susan Wing Lipinski, M.D. October 16, 2013. Learning Objectives. To become familiar with non-invasive options for prenatal testing and the appropriate indications for use

mason
Télécharger la présentation

Topics in High Risk OB Advanced maternal age, Twins, VBAC, Preterm labor

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Topics in High Risk OB Advanced maternal age, Twins, VBAC, Preterm labor Susan Wing Lipinski, M.D. October 16, 2013

  2. Learning Objectives • To become familiar with non-invasive options for prenatal testing and the appropriate indications for use • To become familiar with different types of twin gestations and the unique risks associated with each • To understand the risk and benefits associated with a trial of labor after Cesarean section • To become familiar with preventative treatments for preterm labor

  3. Advanced Maternal Age • Age 35 years or older at anticipated date of delivery • Increased risk of miscarriage • Increased risk of trisomies – 13, 18, 21 especially • Increased risk of gestational diabetesand preeclampsia • Increased risk of stillbirth • Number of women delaying childbirth is increasing • 1970 – 1 in 100 first pregnancies to mothers over age 35 yrs • 2006 – 1 in 12

  4. Non-invasive prenatal testing • Quad screen • Integrated screen • Cell-free DNA testing Invasive Prenatal testing = Amniocentesis

  5. Quad screen • Developed from AFP testing into triple marker screen and now quadruple marker screening • First option available to those under age 35 yrs – introduced in 1984 • SCREENING test – not diagnostic • Estimates risk of trisomy 13, 18,21; abdominal wall defects; neural tube defects; indirect information about placenta and risk of preeclampsia. • Blood draw between 15-20 weeks • Alpha-fetoprotein • hCG • Estriol • Inhibin -A

  6. Integrated screen • Takes the Quad screen (2nd trimester screening) and combines with first trimester US of nuchal thickness and first trimester biochemical markers • Done at 11-13 weeks • Detection rate for Down Syndrome 94-96% • Biochemical markers tested • Free B-hCG • PAPP-A (pregnancy associated plasma protein A)

  7. Cell-free DNA testing • Newest option available • Only validated in high risk patient populations • Can be done as early as 10 weeks up until 32 weeks • Several tests available – Materniti21 most widely used in this area • Highly accurate at identifying the following: • Trisomy 13, 18, 21 • Sex chromosome aneuploidies (XXY, X0, XYY, XXX) • Identifying gender – important for families with X-lined diseases

  8. Taken from Se Taken from www.sequenom.com

  9. Who gets Cell-free DNA test? • Age over 35 years • Personal or family history of chromosomal abnormalities • Fetal ultrasound suggestive of aneuploidy • Positive screening test

  10. Prevention of stillbirth • Unclear etiology • Studies do not support placental insuffiency as cause • Studies do show benefits of NST testing • OR of stillbirth compared to age 25-29 yrs • 35-39 yrs OR is 1.8 – 2.2 • 40+ yrs OR is 1.8-3.3 • When to test? • Start 36-38 weeks then test weekly till delivery • Some benefit to twice weekly testing for those over age 40 yrs • Some benefit to delivery at 39 weeks in those over 40 yrs.

  11. Twins

  12. Monozygotic vs. Dizygotic • Dizygotic are always Dichorionic/Diamniotic • Monozygotic can be any type of chorionicity/amnionicity • Dichorionic/Diamniotic twins • 85% dizygotic • 15% monozygotic

  13. Embryologic development monozygotic twins Morula Days 1-3 Dichorionic/Diamniotic Blastocyst Days 4-8 Monochorionic/Diamniotic Implanted Blastocyst Days 8-13 Monochorionic/ Monoamniotic Formed Embyonic disc Days 13-15 Conjoined twins

  14. US identification of twin chorionicity • Best determined in first trimester • Absolutely necessary to know in order to determine appropriate follow up! • Twin peak sign - “Heaping up” of villi into intermembrane space

  15. Risks associated with all twin gestations • Preterm labor • Small birth weight and IUGR • Gestational diabetes • Preeclampsia, Acute fatty liver of pregnancy • DVT/PE • Cerebral palsy – 4 times that of a singleton pregnancy! • Increased risk of admission to NICU Since 1980 there has been a 65% increase in twins and 500% increase in triplets and higher-order births!

  16. Risks unique to Mono/Di Twins • Twin-to-Twin transfusion syndrome (TTTS) – 10-15% of Mono/di twins • Twin anemia-polycythemia sequence (TAPS) – variant of TTTS with normal amniotic fluid volumes • Twin reversed arterial perfusion sequence (TRAP) – acardiac twin uses co-twin for perfusion. 1% of mono/di • Selective intrauterine growth restriction • Early identification of all of these results in the best outcome – this is the area where intrauterine surgery is taking off!

  17. Twin-to-Twin Transfusion

  18. Risks Unique to Mono/Mono twins • 1 in 10,000 pregnancies • Twin-to-Twin transfusion is less common but possible • Cord entanglement • Begins in first trimester • Results in up to 23% mortality in utero

  19. Monitoring of twin pregnancies • All twin gestations need growth US every 4 weeks through out pregnancy • Monochorionic should have q2 week US from 16-28 to screen for TTTS and its variants • NST screening should be done in 3rd trimester on all twins • Monochorionic/Monoamniotic twins should be referred to tertiary care center for hospitalized monitoring in 3rd trimester

  20. Trial of Labor after Cesarean section – the VBAC controversy

  21. Why all the fuss? • 30.8% of deliveries in Iowa were C/sections last year • <20% of women have a VBAC • Serious potential risks with BOTH Cesarean delivery and VBAC • ACOG practice bulletin in 2004 used the following wording “immediate availability of Cesarean section.” • This was interpreted to mean immediate surgical availability and therefore, in-house surgeon and anesthesia • As a result, many smaller hospitals discontinued VBAC’s and required RLTCS • Wording was revised in 2010 to try to promote more VBAC’s

  22. What the evidence shows - • Most maternal morbidity during a trial of labor occurs when repeat LTCS becomes necessary • Overall risks for maternal complications in repeat LTCS or VBAC are very low • For those with successful VBAC there are significant health advantages • Minimal difference in neonatal morbidity between elective repeat LTCS and trial of labor • Probability of successful VBAC is 60-80% • Risks for VBAC after 2 Cesarean deliveries is only minimally increased

  23. What do we do with this info? • Counsel patients about the true risks • There are VERY few absolute contraindications • Decisions should be on case-by-case basis • Start the conversations about VBAC/RLTCS early in pregnancy • Support a patient’s right to choose her delivery route • Respect for patient autonomy argues that even if a hospital does not “offer VBAC” you cannot force a woman to have a Cesarean delivery

  24. Preterm labor • Delivery between 20 0/7 weeks to 36 6/7 weeks • In 2010 12% of infants were born before 37 completed weeks • Risks associated with preterm birth follow the child into early childhood • Greatest predictor is history of a prior preterm birth

  25. Options for prevention • Progesterone supplementation from 16-36 weeks • Vaginal – Progesterone suppositories 100-200 mg nightly • IM injection – Makena and compounded 17 HP weekly • No proven benefit in twin gestation • Should be offered to EVERYONE with history of spontaneous preterm birth • Cerclage • Controversial • No proven benefit in twin gestation

  26. Following up a history of Preterm labor • Start with counselling at first OB visit • Look for preventable causes such as STD’s, UTI’s, smoking, substance abuse, low body weight (BMI<19) • Offer Progesterone therapy • Ultrasound for cervical length q 2 weeks from 16-23 weeks • If cervical length 25-29 mm then move to weekly US • If cervical length <25 mm then refer for possible cerclage placement

  27. Bibliography • ACOG Practice Bulletin #77 – Screening for Fetal Chromosomal Abnormalities • Reddy et. al. Maternal age and the risk of stillbirth throughout pregnancy in the United States. Am J Obstet Gyn. 195: 764-770. (2006) • Bahtiyar et. al. Stillbirth at term in women of advanced maternal age in the United States: when could the antenatal testing be initiated? Am J. Perinatology. 25(5): 301-304. (2008) • ACOG Practice Bulletin #56 – Multiple Gestation: Complicated twin, triplet, and high-order multifetal pregnancy • Uptodate – Monoamniotic twin pregnancy • Uptodate – Twin pregnancy: Prenatal issues • ACOG Practice Bulletin #115 – Vaginal birth after previous Cesarean Delivery • ACOG Practice Bulletin #130 – Prediction and Prevention of Preterm birth

More Related